4.6 Article

The Glycolytic Inhibitor 2-Deoxyglucose Activates Multiple Prosurvival Pathways through IGF1R

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Oncology

LKB1 is necessary for Akt-mediated phosphorylation of proapoptotic proteins

Diansheng Zhong et al.

CANCER RESEARCH (2008)

Review Biochemistry & Molecular Biology

The type I insulin-like growth factor receptor pathway: a key player in cancer therapeutic resistance

Angelo J. Casa et al.

FRONTIERS IN BIOSCIENCE-LANDMARK (2008)

Article Multidisciplinary Sciences

Somatic mutations affect key pathways in lung adenocarcinoma

Li Ding et al.

NATURE (2008)

Article Multidisciplinary Sciences

The M2 splice isoform of pyruvate kinase is important for cancer metabolism and tumour growth

Heather R. Christofk et al.

NATURE (2008)

Review Biochemistry & Molecular Biology

Targeting the Raf-MEK-ERK mitogen-activated protein kinase cascade for the treatment of cancer

P. J. Roberts et al.

ONCOGENE (2007)

Review Biochemistry & Molecular Biology

Glycolysis inhibition for anticancer treatment

H. Pelicano et al.

ONCOGENE (2006)

Article Medicine, Research & Experimental

2-Deoxyglucose: An anticancer and antiviral therapeutic, but not any more a low glucose mimetic

HT Kang et al.

LIFE SCIENCES (2006)

Review Oncology

Insulin-like growth factors and neoplasia

MN Pollak et al.

NATURE REVIEWS CANCER (2004)

Review Oncology

A renaissance for SRC

TJ Yeatman

NATURE REVIEWS CANCER (2004)

Review Endocrinology & Metabolism

Cellular actions of the insulin-like growth factor binding proteins

SM Firth et al.

ENDOCRINE REVIEWS (2002)

Review Oncology

The phosphatidylinositol 3-kinase-AKT pathway in human cancer

I Vivanco et al.

NATURE REVIEWS CANCER (2002)